Skip to main content
Home Home

Utility

  • Join Us
  • Support Us
search
  • Our Experts
  • Events & News
    • U-M Events
    • Non U-M Events
    • Events Archive
    • News
  • Research & Impact Programs
  • Enrichment, Training & Funding
  • Partners
  • About

Utility

  • Join Us
  • Support Us
search

Secondary Menu

  • Our Experts
  • Events & News
    • U-M Events
    • Non U-M Events
    • Events Archive
    • News
  • Research & Impact Programs
  • Enrichment, Training & Funding
  • Partners
  • About
  • U-M Events
  • Non U-M Events
  • Events Archive
  • News

New NIDDK COVID-19 - Metabolism Pilot Grants

Monday, November 8, 2021
New COVID-19 - Metabolism Pilot Grants for Diabetes Research Center (DRC) and Center for Diabetes Translational Research (CDTR) Investigators

 

The NIDDK has just announced two new requests for applications (RFAs) to foster collaboration between investigators from two or more different Diabetes Research Centers (DRC) or Centers for Diabetes Translational Research (CDTR).

 

For the first round of these RFAs, applications must be relevant to aspects of COVID-19 disease as it relates to diabetes, obesity or metabolism. 

 

In future years, the scope of these applications may be broadened to all aspects of metabolic diseases or be focused on different emphasis areas.

 

Two funding mechanisms are available:

  • Pilot and Feasibility Grants (P&F): These grants support collaborative efforts between investigators at two or more DRCs or CDTRs. The budget for a P&F grant is up to $100,000.

 

  • Mini-grants: These grants support the use of biomedical core services at DRCs or CDTRs at a different institution and/or by investigators at different DRC or CDTRs initiating a new collaboration. The budget for a Mini-grant is up to $10,000.

 

Details:

 

Applications can be for basic research, clinical research as well as for community-based studies.

 

Investigators at all faculty levels are eligible to apply, but must be members of a DRC or CDTR

 

Collaborations must involve DRC and/or CDTR members at different institutions.

 

The application deadline is February 1, 2022 with an anticipated start date in April 2022

 

F&A costs will not be covered through these grants

 

These two new pilot funding mechanisms will be administered through the Albert Einstein-Mount Sinai DRC.

 

Please see the downloads for the RFA and additional details.

File
P&F RFA 11-1-21.docx (16.74 KB)

 

 

File
Mini-Grant RFA 11-1-21.docx (15.69 KB)

 

 

File
P&F Budget form.docx (17.73 KB)

 

Det är inte så lätt att säga, eftersom det verkligen beror på personen. Vissa människor tolererar ett läkemedel bättre, andra det andra. Sildenafil varar dock kortare än köpa cialis receptfritt (den senare kan ge effekten i upp till 1,5 dagar). Men en sådan förlängd verkningstid är inte alltid fördelaktig, särskilt om en patient tar läkemedel som kan interagera med tadalafil.

Michigan Medicine

  • Find a Doctor
  • Health Research Studies
  • Conditions & Treatments
  • For Health Providers
  • Maps & Directions

Medical School

  • School Administration
  • Education & Training
  • Departments & Centers
  • Office of Research
  • Contact Us
  • Jobs

Sitemap

  • Our Experts
  • Events & News
  • Research & Impact Programs
  • Enrichment, Training & Funding
  • Partners
  • About
©2026 Regents of the University of Michigan | Disclaimer | Privacy Statement | Nondiscrimination Policy
Produced by Michigan Creative, a unit of the Office of the Vice President for Communications